Clinical Trial Update: Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the early bactericidal activity of sitafloxacin against Mycobacterium abscessus disease is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Disease

Drugs mentioned

• Sitafloxacin (sitafloxacin)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Fluoroquinolone, Mycobacterium | Phase 2 | Status: ENROLLING_BY_INVITATION